NRC Stock Overview
Provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
National Research Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$31.00 |
| 52 Week High | US$47.25 |
| 52 Week Low | US$28.51 |
| Beta | 0.47 |
| 1 Month Change | -8.90% |
| 3 Month Change | -20.98% |
| 1 Year Change | -28.12% |
| 3 Year Change | -38.88% |
| 5 Year Change | -39.56% |
| Change since IPO | 55.00% |
Recent News & Updates
Recent updates
Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)
May 09
National Research's (NASDAQ:NRC) Dividend Will Be $0.12
Feb 20National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Dec 13Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital
Oct 01We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt
Jul 10Why We Like The Returns At National Research (NASDAQ:NRC)
May 04Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
Mar 25National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Nov 17National Research Corp: Market Is Discounting These Key Factors
Sep 18National Research declares $0.24 dividend
Aug 23National Research GAAP EPS of $0.33, revenue of $37.3M
Aug 02National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively
Jul 13Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
May 27National Research Corp.: Quality/Low Risk On Sale
May 17The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested
Mar 21National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly
Feb 11National Research (NASDAQ:NRC) Is Achieving High Returns On Its Capital
Nov 25Is National Research (NASDAQ:NRC) A Risky Investment?
Nov 02Shareholder Returns
| NRC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -0.2% | 1.5% | 1.7% |
| 1Y | -28.1% | 6.9% | 26.3% |
Return vs Industry: NRC underperformed the US Healthcare industry which returned 6.9% over the past year.
Return vs Market: NRC underperformed the US Market which returned 26.3% over the past year.
Price Volatility
| NRC volatility | |
|---|---|
| NRC Average Weekly Movement | 6.7% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NRC's share price has been volatile over the past 3 months.
Volatility Over Time: NRC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 435 | Mike Hays | www.nrchealth.com |
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.
National Research Corporation Fundamentals Summary
| NRC fundamental statistics | |
|---|---|
| Market cap | US$740.01m |
| Earnings (TTM) | US$30.36m |
| Revenue (TTM) | US$147.42m |
24.4x
P/E Ratio5.0x
P/S RatioIs NRC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NRC income statement (TTM) | |
|---|---|
| Revenue | US$147.42m |
| Cost of Revenue | US$55.59m |
| Gross Profit | US$91.83m |
| Other Expenses | US$61.47m |
| Earnings | US$30.36m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.27 |
| Gross Margin | 62.29% |
| Net Profit Margin | 20.59% |
| Debt/Equity Ratio | 113.9% |
How did NRC perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield39%
Payout RatioDoes NRC pay a reliable dividends?
See NRC dividend history and benchmarks| National Research dividend dates | |
|---|---|
| Ex Dividend Date | Jun 28 2024 |
| Dividend Pay Date | Jul 15 2024 |
| Days until Ex dividend | 39 days |
| Days until Dividend pay date | 56 days |
Does NRC pay a reliable dividends?
See NRC dividend history and benchmarks